| Structure | Chemical Name | CAS | MF |
|
EDA-A2, SOLUBLE (HUMAN)
|
|
|
|
|
EDA-A1, SOLUBLE (HUMAN)
|
|
|
|
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
|
25952-53-8
|
C8H18ClN3
|
|
|
ECK/FC CHIMERA
|
|
|
|
|
EDA FOLATE, [3H]-
|
|
|
|
|
EDA FOLATE, [3H]- 1-10 CI(37-370 GBQ)/MMOL, DELIVERED >= 95% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
|
EBTR CELL LYSATE
|
|
|
|
|
EDAG protein
|
|
|
|
|
EBV
|
|
|
|
1,2-Dibromoethane
|
106-93-4
|
C2H4Br2
|
|
ECLALBASAPONIN I
|
158511-59-2
|
C42H68O14
|
|
ECLALBASAPONIN VI
|
158511-63-8
|
C42H68O17S
|
|
|
Eclalbasaponin Ⅺ3-O-[β-D-Glucopyranosyl(1→2)-β-D-Glucopyranosyl]-16α-ethoxy-olean-12-ene-28-oic acid-28-O-β-D-glucopyranoside
|
|
C50H82O19
|
|
|
Eclalbasaponin Ⅻ3-O-[(2-O-sulfuryl-β-D-glucopyranosyl)(1→2)-β-D-glucopyranosyl]-echinocystic acid-28-O-β-D-glucopyranoside
|
|
C48H78O22S
|
|
Eclanamine
|
71027-13-9
|
C16H22Cl2N2O
|
|
|
EBVB95-8 Direct Pelleted Virus w/TCID50
|
|
|
|
|
EBV Antigen Lysate
|
|
|
|
|
EBV anti-Capsid protein p160
|
|
|
|
|
EBVB95-8 DNA
|
|
|
|
|
Ebulin 1, Sambucus ebulus L.
|
|
|
|
|
EBV-associated membrane antigen
|
|
|
|
|
ebulin r
|
|
|
|
|
EBULIN 1
|
|
|
|
|
EDAMAME
|
|
|
|
|
ECL BLOCKING AGENT
|
|
|
|
ECKLONIALACTONE F
|
149633-57-8
|
C20H30O4
|
|
ecklonialactone A
|
121923-95-3
|
C18H26O3
|
|
|
E-C-L CELL ATTACHMENT MATRIX
|
|
|
|
ecklonialactone B
|
121923-96-4
|
C18H28O3
|
|
ecklonialactone E
|
149633-56-7
|
C20H28O3
|
|
|
EBVB95-8 Purified Virus
|
|
|
|
Eclazolast
|
80263-73-6
|
C12H12ClNO4
|
|
|
EDAM FLAVOUR
|
|
|
|
|
EBVB95-8 Quantitated Viral DNA
|
|
|
|
Edan
|
7194-12-9
|
C15H21NO4
|
|
|
EDB/DBCP/123TCA Standards Mixture - 504.1
|
|
|
|
|
EDB/DBCP/123TCA Standards Mixture - 504.1 (repkg)
|
|
|
|
|
EBVB95-8 Viral Lysate
|
|
|
|
|
EDB/DBCP/123TCA STANDARDS MIXTURE
|
|
|
|
(23E)-5α-Dammar-23-ene-3α,12β,17,20,25-pentol
|
63955-93-1
|
C30H52O5
|
|
(23E)-5α-Dammar-23-ene-3β,20,25-triol
|
53822-99-4
|
C30H52O3
|
|
|
(23E)-Dammar-23-ene-3α,12β,20,25-tetrol
|
|
|
|
(23E)-Dammara-20,23-diene-3β,25-diol
|
101559-95-9
|
C30H50O2
|
|
(23E)-Dammaran-23-ene-3β,25-diol
|
101559-94-8
|
C30H52O2
|
|
|
EBVD protocol
|
|
|
|
1,5-EDANS
|
50402-56-7
|
C12H14N2O3S
|
|
EDANS C2 MALEIMIDE
|
2149639-01-8
|
C16H14N2O5S
|
|
1,5-EDANS SODIUM SALT
|
100900-07-0
|
C12H13N2NaO3S
|
|
|
EDANS NOVATAG RESIN
|
|
|
|
eckol
|
88798-74-7
|
C18H12O9
|
|
|
EBV-encoded nuclear antigen 1
|
|
|
|
|
(13E)-3,13-Clerodadiene-15,17-dial
|
|
|
|
|
EDAP regimen
|
|
|
|
|
EDA1 protein
|
|
|
|
|
EDA PS RESIN
|
|
|
|
|
edaravone iMpurity C
|
|
|
|
|
edaravone iMpurity B
|
|
|
|
|
edaravone iMpurity A
|
|
|
|
Edaravone iMpurity P3
|
1323485-71-7
|
C13H16N2O4S
|
|
5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one
|
89-25-8
|
C10H10N2O
|
|
Eburenine, (-)-
|
56245-51-3
|
C19H24N2
|
|
|
EBV (HHV-4) p23, Recomb. Purified
|
|
|
|
|
EDAR (HUMAN):FC (HUMAN)
|
|
|
|
|
EBV (HHV-4) EA-D Recombinant Purified
|
|
|
|
|
Eburicyl acetate
|
|
C33H54O2
|
|
Eburical
|
35241-57-7
|
C31H50O2
|
|
|
Eburicol
|
|
C31H52O
|
|
EBURICOIC ACID
|
|
C31H50O3
|
|
Eburicodiol
|
35241-56-6
|
C31H52O2
|
|
1,2-Dichloroethane
|
107-06-2
|
C2H4Cl2
|
|
|
ECLHK I
|
|
|
|
Eburnamonine, 11-methoxy-
|
4800-93-5
|
C20H24N2O2
|
|
(-)-EBURNAMONINE
|
4880-88-0
|
C19H22N2O
|
|
EBURNAMONINE, (-)-(REAGENT / STANDARD GRADE)
|
|
C19H22N2O
|
|
Eburnamine
|
473-99-4
|
C19H24N2O
|
|
|
(3α,16α)-Eburnamenine-14-carboxylic acid allyl ester
|
|
|
|
|
[3α,(+)]-Eburnamenine
|
|
|
|
|
(3α,16α)-Eburnamenine-14-carboxylic acid 2,2,2-trifluoroethyl ester
|
|
|
|
|
(3α,16α)-Eburnamenine-14-carboxylic acid 2-chloroethyl ester
|
|
|
|
|
(3α,16α)-Eburnamenine-14-carboxylic acid 2-hydroxyethyl ester
|
|
|
|
Eburnamenine
|
517-30-6
|
C19H22N2
|
|
|
(3α,16α)-Eburnamenine-14-carboxylic acid 3-hydroxypropyl ester
|
|
|
|
EBURNAMENINE-14-CARBOXYLIC ACID, 14,15-DIHYDRO-14-HYDROXY-, ETHYL ESTER, (3A,14B,16A)-
|
40163-56-2
|
C22H28N2O3
|
|
|
ECL136II
|
|
|
|
2-[(1E)-buta-1,3-dienyl]-1,3,3-trimethyl-cyclohexene
|
|
C13H20
|
|
[(1E)-buta-1,3-dienyl]azanium, 2-methylprop-2-enoic acid
|
67801-77-8
|
C8H14NO2+
|
|
5-((E)-BUTA-1,3-DIENYL)-4-HYDROXY-3,5-DIMETHYL-5H-THIOPHEN-2-ONE
|
|
C10H12O2S
|
|
2-((E)-BUTA-1,3-DIENYL)-1,3,5-TRIMETHOXY-BENZENE
|
|
C13H16O3
|
|
(1E)-Butanal (2E)-2-butenylhydrazone
|
36566-74-2
|
|
|
[(1E)-1,3-Butadienyl]methyl ether
|
|
C10H14O
|
|
[(E)-1,3-Butadienyl]p-tolyl sulfoxide
|
|
C11H12OS
|
|
(1E)-1,3-Butadien-1-ol
|
|
C4H6O
|
|
3-[(E)-1,3-Butadienyl]-2,4,4,5-tetramethyl-2-cyclohexen-1-one
|
68931-37-3
|
|
|
|
EBV-Induced Gene 2 (EBI2)
|
|
|
|
|
EBV-Induced Gene 2 (EBI2) C
|
|
|
|
|
EBV-Induced Gene 2 (EBI2) B
|
|
|
|
|
EBV-Induced Gene 2
|
|
|
|
(E)-2-(1-Butenyl)-1,3,2-benzodioxaborole
|
106094-36-4
|
C10H11BO2
|
|
3-[((E)-But-2-enyl)oxyMethyl]-4-iodo-2-Methoxy-6-triMethylsilanyl-pyridine
|
174092-76-3
|
C14H22INO2Si
|
|
2-[(2E)-but-2-enylthio]nicotinic acid
|
|
C10H11NO2S
|